PRIMASPAN

Main information

  • Trade name:
  • PRIMASPAN 250 mg gastro-resistant tablet
  • Dosage:
  • 250 mg
  • Pharmaceutical form:
  • gastro-resistant tablet
  • Prescription type:
  • No Prescription (OTC)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • PRIMASPAN 250 mg gastro-resistant tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Acetylsalicylic acid
  • Product summary:
  • Suitability for use in older adult patients Acidum acetylsalicylicum Suitable for older persons, with specific cautions. A significant adverse effect is increased risk of bleeding. Suitable in small doses (= 100 mg/ day) for secondary prevention of arterial disease.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 8121
  • Authorization date:
  • 15-01-2009
  • Last update:
  • 21-02-2018